Lamiter (Terbinafine Hydrochloride)

Terbinafine blocks the fungal enzyme squalene epoxidase, preventing the synthesis of ergosterol, an essential component of fungal cell membranes. The resulting accumulation of squalene and loss of ergosterol disrupts membrane integrity, leading to fungal cell death.

The dosage of Lamiter is determined by the prescribing healthcare professional. For topical use, the typical instruction is to apply a thin layer to the affected area once daily for the duration recommended by the clinician.

Safety data for topical terbinafine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamiter.

To order Lamiter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamiter (terbinafine) belongs to the allylamine class, which targets squalene epoxidase, whereas azole antifungals inhibit lanosterol 14α‑demethylase. Allylamines often achieve faster fungal clearance for dermatophyte infections and have a lower potential for drug‑drug interactions compared with many azoles.

Lamiter should be stored at temperatures below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Lamiter is applied topically. Clean and dry the affected skin area, then spread a thin layer of the product over the lesion and a small margin of surrounding skin. Wash hands before and after application unless the hands are being treated.

Serious adverse reactions, although rare, include severe allergic responses such as contact dermatitis, urticaria, angioedema, and Stevens‑Johnson syndrome. Systemic absorption can rarely affect liver enzymes, so any signs of jaundice or unexplained fatigue should prompt immediate medical evaluation.

Lamiter should not be used by individuals with a known hypersensitivity to terbinafine or any component of the formulation. It is also contraindicated in children under two years of age unless specifically directed by a qualified healthcare professional.